RELMADA THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Relmada Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
  • Relmada Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $8.3M, a 26.9% decline year-over-year.
  • Relmada Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $43.8M, a 0.87% decline from 2022.
  • Relmada Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $44.2M, a 9.14% increase from 2021.
  • Relmada Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $40.5M, a 94.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $43.8M -$384K -0.87% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $44.2M +$3.7M +9.14% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $40.5M +$19.7M +94.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $20.8M +$17.6M +556% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 $3.17M +$2.65M +511% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
2018 $518K -$187K -26.5% Jul 1, 2017 Jun 30, 2018 10-KT 2020-03-26
2017 $705K -$503K -41.6% Jul 1, 2016 Jun 30, 2017 10-K 2018-09-28
2016 $1.21M +$410K +51.5% Jul 1, 2015 Jun 30, 2016 10-K 2017-09-28
2015 $797K Jul 1, 2014 Jun 30, 2015 10-K 2016-09-09
2013 $382K Jan 1, 2013 Dec 31, 2013 10-K 2015-09-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.